2 results
Approved WMOCompleted
Primary: to assess the effect of intravenous (IV) ozanezumab (15 mg/kg once every 2 weeks) compared to placebo on the physical function and survival of ALS patients over a treatment period of 48-weeks.Secondary (major): other clinical outcomes,…
Subjective assessment of amplitude-modulated music by hearing aid wearers and cochlear implant users
The main objective is to assess the perceived sound quality of different music excerpts that are modified using the modulation-depth algorithm (MDA) of Golden Hearing by CI users and hearing aid (HA) wearers. To this end a suitable graphical user…